AstraZeneca, Rigel Sign Potentially $100M Asthma Drug Deal
Genetic Engineering News Drug firm will start first-in-man studies and carry out clinical development program for R256. |
View full post on asthma – Google News
AstraZeneca, Rigel Sign Potentially $100M Asthma Drug Deal
Genetic Engineering News Drug firm will start first-in-man studies and carry out clinical development program for R256. |
View full post on asthma – Google News